Organogenesis Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

-0.01 (-0.70%)

As of Sep 21, 3:10 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +492.2% upside

Low Target $5.30

Average Target $8.35

High Target $10.56

Current Price $1.41

Current
$1.41

Target
$8.35

$5.30 $8.35 avg $10.56

Scenario Analysis

Bear Case

$5.30

275.9%

Low target

Base Case

$8.35

+492.2%

Avg target

Bull Case

$10.56

+648.9%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$7.08

-80.1% from high

52-Week Low

$1.36

+4.1% from low

Target vs 52W High

$8.35

+18.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%